Form 8-K - Current report:
SEC Accession No. 0001193125-23-043538
Filing Date
2023-02-21
Accepted
2023-02-21 16:30:53
Documents
13
Period of Report
2023-02-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d452156d8k.htm   iXBRL 8-K 27845
2 EX-3.1 d452156dex31.htm EX-3.1 134696
  Complete submission text file 0001193125-23-043538.txt   322301

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ew-20230216.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ew-20230216_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ew-20230216_pre.xml EX-101.PRE 11256
7 EXTRACTED XBRL INSTANCE DOCUMENT d452156d8k_htm.xml XML 3471
Mailing Address ONE EDWARDS WAY IRVINE CA 92614
Business Address ONE EDWARDS WAY IRVINE CA 92614 9492502500
Edwards Lifesciences Corp (Filer) CIK: 0001099800 (see all company filings)

EIN.: 364316614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15525 | Film No.: 23648671
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies